Advanced Search

Immunotherapy Stocks List

Symbol Grade Name % Change
CLDX A Celldex Therapeutics, Inc. -1.56
FBIO C Fortress Biotech, Inc. 0.27
CDMO A Avid Bioservices, Inc. 8.60
CVM C Cel-Sci Corporation -3.32
IMUX F Immunic, Inc. 1.98
GNCA C Genocea Biosciences, Inc. 2.01
ATNM F Actinium Pharmaceuticals, Inc. 2.41
ENLV C Enlivex Therapeutics Ltd. 1.19
DBVT C DBV Technologies S.A. -0.19
APTO F Aptose Biosciences, Inc. -0.50
BLCM D Bellicum Pharmaceuticals, Inc. -2.24
IOVA F Iovance Biotherapeutics, Inc. 2.16
CDTX F Cidara Therapeutics, Inc. -6.58
ADAP F Adaptimmune Therapeutics plc -6.73
ONCS F OncoSec Medical Incorporated 0.00
CLBS F Caladrius Biosciences, Inc. -6.81
ALPN D Alpine Immune Sciences, Inc. 2.72
PDSB C PDS Biotechnology Corporation -8.76
CNCR D Loncar Cancer Immunotherapy ETF 0.32
SELB C Selecta Biosciences, Inc. -1.40
MRKR C Marker Therapeutics, Inc. -1.63
JNCE C Jounce Therapeutics, Inc. -6.63
URGN F UroGen Pharma Ltd. -5.93
ARGX B argenx SE -2.59
IMRN F Immuron Limited -2.32
MBIO F Mustang Bio, Inc. 2.32
FBIOP B Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock 0.63
CDMOP A Avid Bioservices, Inc. - 10.50% Series E Convertible Preferred Stock 0.97
SURF F Surface Oncology, Inc. 0.47
IMV F IMV Inc. -0.60
REPL F Replimune Group, Inc. -0.35
ARDS F Aridis Pharmaceuticals Inc. 2.44
GRTS C Gritstone Oncology, Inc. 2.26
AVCO F Avalon GloboCare Corp. -4.00
INMB D INmune Bio Inc. -0.18
HARP C Harpoon Therapeutics, Inc. 5.35
TCRR F TCR2 Therapeutics Inc. -1.64
DTIL A Precision BioSciences, Inc. 7.46
NXTC F NextCure, Inc. -1.73
LCTX C Lineage Cell Therapeutics, Inc. 0.44
IPHA D Innate Pharma S.A. 1.58
THMO D ThermoGenesis Holdings, Inc. -8.36
ORIC D Oric Pharmaceuticals, Inc. -7.11
ADTX C ADiTx Therapeutics, Inc. -3.50
IMTX D Immatics N.V. -1.64
NKTX F Nkarta, Inc. -0.08
PAND A Pandion Therapeutics Inc. 0.65
CMPI F Checkmate Pharmaceuticals, Inc. -5.67
HGEN D Humanigen, Inc. 3.16
GLSI F Greenwich LifeSciences, Inc. -3.98
ONCR F Oncorus, Inc. -3.89
NBTX F Nanobiotix S.A. 0.84
SNSE F Sensei Biotherapeutics, Inc. 1.29
EVAX F Evaxion Biotech A/S -6.07
IMCR F Immunocore Holdings plc -1.31
ADAG F Adagene Inc. -1.45
NEXI C NexImmune, Inc. 0.54
View As Page of Charts
Related Industries: Biotechnology Medical Care Medical Devices
Related Stock Lists: Medicine Cancer Clinical Medicine Immune System Virotherapy Biopharmaceutical Cancer Immunotherapy Cancer Treatments Biotechnology Immunotherapies Immunology Solid Tumors Oncology Autoimmune Diseases Melanoma Treatment Of Cancer Autoimmune Disease Biology Cell Therapy Clinical Development

Related ETFs - A few ETFs which own one or more of the above listed Immunotherapy stocks.

Symbol Grade Name Weight
CNCR D Loncar Cancer Immunotherapy ETF 12.7
AADR C WCM BNY Mellon Focused Growth ADR ETF 6.19
BBC D Virtus LifeSci Biotech Clinical Trials ETF 4.43
IBBJ D Defiance Nasdaq Junior Biotechnology ETF 4.11
ARKG D ARK Genomic Revolution Multi-Sector ETF 3.9
View all Immunotherapy related ETFs...
Compare ETFs
  • Compare AADR to BBC
  • Compare CNCR to AADR
  • Compare IBBJ to ARKG

    • Recent Signals

    Date Stock Signal Type
    2021-02-26 ADAG New 52 Week Closing Low Bearish
    2021-02-26 ADAG Hot IPO Pullback Bullish Swing Setup
    2021-02-26 ADAP Fell Below 50 DMA Bearish
    2021-02-26 ADTX Narrow Range Bar Range Contraction
    2021-02-26 ADTX 50 DMA Support Bullish
    2021-02-26 ALPN Stochastic Buy Signal Bullish
    2021-02-26 ALPN Pocket Pivot Bullish Swing Setup
    2021-02-26 ALPN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-02-26 APTO NR7 Range Contraction
    2021-02-26 APTO New 52 Week Low Weakness
    2021-02-26 APTO New 52 Week Closing Low Bearish
    2021-02-26 APTO Lower Bollinger Band Walk Weakness
    2021-02-26 ARDS Hammer Candlestick Bullish
    2021-02-26 ARDS Lower Bollinger Band Walk Weakness
    2021-02-26 ARDS Lizard Bullish Bullish Day Trade Setup
    2021-02-26 ARGX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-02-26 ATNM New Downtrend Bearish
    2021-02-26 ATNM Spinning Top Other
    2021-02-26 AVCO 50 DMA Resistance Bearish
    2021-02-26 BLCM NR7 Range Contraction
    2021-02-26 BLCM 50 DMA Support Bullish
    2021-02-26 CDMO Stochastic Reached Overbought Strength
    2021-02-26 CDMO New 52 Week Closing High Bullish
    2021-02-26 CDMO New 52 Week High Strength
    2021-02-26 CDMO Pocket Pivot Bullish Swing Setup
    2021-02-26 CDMO MACD Bullish Signal Line Cross Bullish
    2021-02-26 CDMOP 20 DMA Support Bullish
    2021-02-26 CDMOP Hammer Candlestick Bullish
    2021-02-26 CDTX Fell Below 50 DMA Bearish
    2021-02-26 CLBS New Downtrend Bearish
    2021-02-26 CLBS MACD Bearish Centerline Cross Bearish
    2021-02-26 CLBS Fell Below 200 DMA Bearish
    2021-02-26 CLBS Fell Below 50 DMA Bearish
    2021-02-26 CNCR New Downtrend Bearish
    2021-02-26 CNCR Stochastic Reached Oversold Weakness
    2021-02-26 DBVT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-02-26 DBVT 1,2,3 Pullback Bullish Bullish Swing Setup
    2021-02-26 DBVT Bollinger Band Squeeze Range Contraction
    2021-02-26 DTIL Crossed Above 50 DMA Bullish
    2021-02-26 DTIL 180 Bullish Setup Bullish Swing Setup
    2021-02-26 ENLV NR7 Range Contraction
    2021-02-26 EVAX Hot IPO Pullback Bullish Swing Setup
    2021-02-26 EVAX New 52 Week Closing Low Bearish
    2021-02-26 FBIO 20 DMA Resistance Bearish
    2021-02-26 FBIOP Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-02-26 FBIOP NR7 Range Contraction
    2021-02-26 FBIOP Narrow Range Bar Range Contraction
    2021-02-26 FBIOP 1,2,3 Pullback Bullish Bullish Swing Setup
    2021-02-26 GLSI Lower Bollinger Band Walk Weakness
    2021-02-26 GLSI 1,2,3 Pullback Bullish Bullish Swing Setup
    2021-02-26 GNCA NR7 Range Contraction
    2021-02-26 GNCA 50 DMA Support Bullish
    2021-02-26 HARP 20 DMA Resistance Bearish
    2021-02-26 HARP Crossed Above 50 DMA Bullish
    2021-02-26 HARP Pocket Pivot Bullish Swing Setup
    2021-02-26 HGEN 50 DMA Resistance Bearish
    2021-02-26 IMCR Hot IPO Pullback Bullish Swing Setup
    2021-02-26 IMRN MACD Bearish Centerline Cross Bearish
    2021-02-26 IMTX Bollinger Band Squeeze Range Contraction
    2021-02-26 IMTX Volume Surge Other
    2021-02-26 IMTX Fell Below 50 DMA Bearish
    2021-02-26 IMUX Calm After Storm Range Contraction
    2021-02-26 IMV NR7 Range Contraction
    2021-02-26 INMB Lower Bollinger Band Walk Weakness
    2021-02-26 IOVA Crossed Above 200 DMA Bullish
    2021-02-26 IOVA Lower Bollinger Band Walk Weakness
    2021-02-26 IOVA Pocket Pivot Bullish Swing Setup
    2021-02-26 IPHA 50 DMA Support Bullish
    2021-02-26 IPHA 20 DMA Support Bullish
    2021-02-26 IPHA MACD Bullish Signal Line Cross Bullish
    2021-02-26 JNCE 20 DMA Resistance Bearish
    2021-02-26 JNCE Bearish Engulfing Bearish
    2021-02-26 LCTX Doji - Bullish? Reversal
    2021-02-26 LCTX Stochastic Reached Oversold Weakness
    2021-02-26 LCTX 50 DMA Support Bullish
    2021-02-26 MBIO Crossed Above 200 DMA Bullish
    2021-02-26 MBIO Lower Bollinger Band Walk Weakness
    2021-02-26 MBIO Doji - Bullish? Reversal
    2021-02-26 MBIO New Downtrend Bearish
    2021-02-26 MRKR Spinning Top Other
    2021-02-26 NBTX Stochastic Buy Signal Bullish
    2021-02-26 NBTX Lower Bollinger Band Walk Weakness
    2021-02-26 NEXI New 52 Week Closing High Bullish
    2021-02-26 NKTX Spinning Top Other
    2021-02-26 NKTX MACD Bearish Signal Line Cross Bearish
    2021-02-26 NXTC Stochastic Buy Signal Bullish
    2021-02-26 ONCS Lower Bollinger Band Walk Weakness
    2021-02-26 ORIC Fell Below 50 DMA Bearish
    2021-02-26 ORIC Fell Below 20 DMA Bearish
    2021-02-26 PDSB Stochastic Reached Oversold Weakness
    2021-02-26 SELB Stochastic Buy Signal Bullish
    2021-02-26 SNSE Hot IPO Pullback Bullish Swing Setup
    2021-02-26 SURF Lower Bollinger Band Walk Weakness
    2021-02-26 SURF New Downtrend Bearish
    2021-02-26 TCRR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-02-26 TCRR Bollinger Band Squeeze Range Contraction
    2021-02-26 TCRR 20 DMA Resistance Bearish
    2021-02-26 THMO 50 DMA Support Bullish
    2021-02-26 THMO New Downtrend Bearish
    2021-02-26 URGN MACD Bearish Centerline Cross Bearish

    Recent News for Immunotherapy Stocks

    Date Stock Title
    Feb 27 PAND SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND
    Feb 26 JNCE Jounce Therapeutics, Inc. (JNCE) Q4 2020 Earnings Call Transcript
    Feb 26 NXTC NextCure to Host Virtual R&D Update Event on March 4, 2021
    Feb 26 PAND Moore Kuehn Encourages SFTW, PRAH, RTP, and PAND Investors to Contact Law Firm
    Feb 26 IOVA Iovance (IOVA) Q4 Earnings Miss Estimates, Pipeline in Focus
    Feb 26 PAND Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout
    Feb 26 PAND Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021
    Feb 26 IOVA Iovance Biotherapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
    Feb 26 FBIOP Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
    Feb 26 FBIOP Mustang Bio Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
    Feb 26 FBIO Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
    Feb 26 FBIO Mustang Bio Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
    Feb 26 MBIO Mustang Bio Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
    Feb 26 IMUX Immunic EPS beats by $0.05
    Feb 26 CLBS Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q4 2020 Results - Earnings Call Transcript
    Feb 26 PAND Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket
    Feb 26 IOVA Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q4 2020 Results - Earnings Call Transcript
    Feb 26 PAND INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER
    Feb 26 PAND Why Pandion Therapeutics Stock Shot Up 133% Today
    Feb 26 PAND SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Pandion Therapeutics, Inc. (Nasdaq - PAND)
    Related Industries: Biotechnology Medical Care Medical Devices
    Related Stock Lists: Medicine Cancer Clinical Medicine Immune System Virotherapy Biopharmaceutical Cancer Immunotherapy Cancer Treatments Biotechnology Immunotherapies Immunology Solid Tumors Oncology Autoimmune Diseases Melanoma Treatment Of Cancer Autoimmune Disease Biology Cell Therapy Clinical Development

    Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

    In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
    Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

    More about Immunotherapy
    Browse All Tags